Medicenna Therapeutics is a clinical-stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). Their mission is to become the leader in the development and commercialization of targeted ECs and Superkines for the treatment of a broad range of cancers and immune-mediated diseases.

Biotechnology

Medicenna Therapeutics

Fahar Merchant

Eamonn Peters, CPA, CA

Temi Adeyemo

Manjunatha Ankathatti Munegowda, DVM, MS, PhD, mMBA

Hardeep Kataria

Ambica Rampal

Aanchal Sharma, PhD

Martin Bexon

Rosemina Merchant

The Leadership Team at Medicenna Therapeutics is responsible for setting the strategic vision and direction of the company, overseeing the development of innovative immunotherapies. This team collaborates closely to guide research and clinical initiatives, ensure regulatory compliance, and drive commercialization efforts, all aimed at positioning Medicenna as a leader in targeted cytokine therapies for cancer and immune-mediated diseases.

Leadership Team

Directors and Associate Directors

Clinical Research Team

Leadership Team

About

Team members

Other teams at Medicenna Therapeutics

Directors and Associate Directors

Clinical Research Team